down arrow

Stepan Co.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US8585861003
USD
45.01
-0.89 (-1.94%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

44.9245.98

52 Week

41.8277.76
Valuation
Technical
Day's Volume

CASH

155.14 k

Shareholding (Mar 2025)

FII

5.51%

Held by 94 FIIs

DII

47.68%

Held by 51 DIIs

Promoter

0.00%

How big is Stepan Co.?

22-Jun-2025

As of Jun 18, Stepan Co. has a market capitalization of 1,455.20 million, with net sales of 2,222.10 million and a net profit of 56.19 million over the latest four quarters. The company reported shareholder's funds of 1,169.93 million and total assets of 2,304.65 million as of Dec 24.

Market Cap: As of Jun 18, Stepan Co. has a market capitalization of 1,455.20 million, classifying it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Stepan Co. reported net sales of 2,222.10 million and a net profit of 56.19 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1,169.93 million and total assets of 2,304.65 million.

Read More

What does Stepan Co. do?

22-Jun-2025

Stepan Co. is a small-cap company that produces specialty and intermediate chemicals, with recent net sales of $593 million and a net profit of $20 million. Key metrics include a P/E ratio of 26.00, a dividend yield of 2.35%, and a market cap of $1.46 billion.

Overview:<BR>Stepan Co. produces specialty and intermediate chemicals and operates in the Specialty Chemicals industry within the small-cap market.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 593 Million (Quarterly Results - Mar 2025)<BR>Most recent Net Profit: 20 Million (Quarterly Results - Mar 2025)<BR>Market-cap: USD 1,455.20 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 26.00<BR>Dividend Yield: 2.35%<BR>Debt Equity: 0.47<BR>Return on Equity: 4.68%<BR>Price to Book: 1.21<BR><BR>Contact Details:<BR>Address: Edens & Winnetka Road, NORTHFIELD IL: 60093<BR>Tel: 1 847 4467500<BR>Fax: 1 847 5012100<BR>Website: https://www.stepan.com/

Read More

Who are in the management team of Stepan Co.?

22-Jun-2025

As of March 2022, the management team of Stepan Co. includes Chairman and CEO Frank Stepan, Lead Independent Director Edward Wehmer, and Independent Directors Michael Boyce, Randall Dearth, Joaquin Delgado, and Gregory Lawton, who oversee the company's strategic direction and governance.

As of March 2022, the management team of Stepan Co. includes the following individuals:<BR><BR>- Mr. Frank Stepan, who serves as the Chairman of the Board and Chief Executive Officer.<BR>- Mr. Edward Wehmer, who is the Lead Independent Director.<BR>- Mr. Michael Boyce, an Independent Director.<BR>- Mr. Randall Dearth, an Independent Director.<BR>- Dr. Joaquin Delgado, an Independent Director.<BR>- Mr. Gregory Lawton, an Independent Director. <BR><BR>This team is responsible for overseeing the company's strategic direction and governance.

Read More

Is Stepan Co. technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, Stepan Co. is in a bearish trend confirmed by multiple indicators, underperforming the S&P 500 with a year-to-date return of -22.87% compared to the S&P 500's 12.22%.

As of 2 September 2025, the technical trend for Stepan Co. has changed from mildly bearish to bearish. The current stance is bearish with strong confirmation from multiple indicators: the MACD is bearish on both weekly and monthly time frames, moving averages are bearish on a daily basis, and the KST is bearish across both weekly and monthly periods. Additionally, Bollinger Bands indicate a bearish trend monthly and mildly bearish weekly. Dow Theory also supports a mildly bearish stance on both time frames.<BR><BR>In terms of performance, Stepan Co. has underperformed significantly compared to the S&P 500, with a year-to-date return of -22.87% versus the S&P 500's 12.22%, and a one-year return of -34.80% compared to the S&P 500's 17.14%.

Read More

Is Stepan Co. overvalued or undervalued?

28-Oct-2025

As of October 24, 2025, Stepan Co. is considered overvalued with a valuation grade of fair, reflected in its high P/E ratio of 26 compared to peers, and significant underperformance against the S&P 500, with a year-to-date return of -28.69% and a 10-year return of -60.99%.

As of 24 October 2025, the valuation grade for Stepan Co. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 26, a Price to Book Value of 1.23, and an EV to EBITDA of 10.60. In comparison to its peers, NewMarket Corp. has a more favorable P/E ratio of 16.30, and ChampionX Corp. shows an even lower P/E of 15.52, suggesting that Stepan Co. is priced higher relative to these competitors.<BR><BR>The stock has underperformed significantly against the S&P 500, with a year-to-date return of -28.69% compared to the index's 15.47%, and a staggering 10-year return of -60.99% against the S&P 500's 227.29%. This substantial underperformance reinforces the notion that Stepan Co. may be overvalued in its current market position.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -11.47% of over the last 5 years

 
2

Negative results in Jun 25

3

With ROCE of 4.45%, it has a attractive valuation with a 1.15 Enterprise value to Capital Employed

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 1,349 Million (Small Cap)

stock-summary
P/E

26.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.56%

stock-summary
Debt Equity

0.47

stock-summary
Return on Equity

4.67%

stock-summary
Price to Book

1.09

Revenue and Profits:
Net Sales:
595 Million
(Quarterly Results - Jun 2025)
Net Profit:
11 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.07%
0%
-9.07%
6 Months
-17.76%
0%
-17.76%
1 Year
-40.47%
0%
-40.47%
2 Years
-47.71%
0%
-47.71%
3 Years
-60.38%
0%
-60.38%
4 Years
-61.34%
0%
-61.34%
5 Years
-61.31%
0%
-61.31%

Stepan Co. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Stepan Co. Faces Valuation Shift Amidst Challenging Financial Metrics and Trends

Stepan Co. Faces Valuation Shift Amidst Challenging Financial Metrics and Trends

Stepan Co., a small-cap specialty chemicals company, has experienced a valuation grade adjustment, now categorized as very expensive. Key financial metrics indicate a higher P/E ratio compared to industry standards, alongside a modest dividend yield and declining performance trends over recent quarters, suggesting a challenging financial landscape.

Read More
Stepan Co. Stock Plummets to New 52-Week Low at $43.15

Stepan Co. Stock Plummets to New 52-Week Low at $43.15

Stepan Co., a small-cap specialty chemicals company, has reached a new 52-week low, reflecting a challenging year with a significant performance decline. The company has a market capitalization of USD 1,349 million, a P/E ratio of 26.00, and has struggled with operational profitability and cash flow issues.

Read More
Stepan Co. Experiences Revision in Its Stock Evaluation Amidst Market Challenges

Stepan Co. Experiences Revision in Its Stock Evaluation Amidst Market Challenges

Stepan Co., a small-cap specialty chemicals firm, has adjusted its valuation amid a challenging year, posting a -36.73% return compared to the S&P 500's gain. Key metrics include a P/E ratio of 26 and a dividend yield of 2.32%, indicating areas for potential improvement in a competitive market.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.58%
EBIT Growth (5y)
-11.47%
EBIT to Interest (avg)
17.57
Debt to EBITDA (avg)
1.95
Net Debt to Equity (avg)
0.47
Sales to Capital Employed (avg)
1.24
Tax Ratio
14.40%
Dividend Payout Ratio
68.74%
Pledged Shares
0
Institutional Holding
89.04%
ROCE (avg)
9.49%
ROE (avg)
9.19%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
1.23
EV to EBIT
25.96
EV to EBITDA
10.60
EV to Capital Employed
1.15
EV to Sales
0.92
PEG Ratio
2.53
Dividend Yield
2.32%
ROCE (Latest)
4.45%
ROE (Latest)
4.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 61 Schemes (46.77%)

Foreign Institutions

Held by 94 Foreign Institutions (5.51%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.24% vs 12.88% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -42.64% vs 479.41% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "594.70",
          "val2": "593.30",
          "chgp": "0.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49.30",
          "val2": "57.60",
          "chgp": "-14.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.50",
          "val2": "4.10",
          "chgp": "34.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.30",
          "val2": "19.70",
          "chgp": "-42.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.20%",
          "val2": "47.70%",
          "chgp": "-1.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.26% vs -16.14% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 25.37% vs -72.69% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,180.30",
          "val2": "2,325.80",
          "chgp": "-6.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "189.50",
          "val2": "177.90",
          "chgp": "6.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.50",
          "val2": "15.90",
          "chgp": "22.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.80",
          "val2": "-14.00",
          "chgp": "51.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "50.40",
          "val2": "40.20",
          "chgp": "25.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.40%",
          "val2": "31.20%",
          "chgp": "0.42%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
594.70
593.30
0.24%
Operating Profit (PBDIT) excl Other Income
49.30
57.60
-14.41%
Interest
5.50
4.10
34.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.30
19.70
-42.64%
Operating Profit Margin (Excl OI)
30.20%
47.70%
-1.75%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.24% vs 12.88% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -42.64% vs 479.41% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,180.30
2,325.80
-6.26%
Operating Profit (PBDIT) excl Other Income
189.50
177.90
6.52%
Interest
19.50
15.90
22.64%
Exceptional Items
-6.80
-14.00
51.43%
Consolidate Net Profit
50.40
40.20
25.37%
Operating Profit Margin (Excl OI)
35.40%
31.20%
0.42%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -6.26% vs -16.14% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 25.37% vs -72.69% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Stepan Co. stock-summary
stock-summary
Stepan Co.
Specialty Chemicals
Stepan Company produces specialty and intermediate chemicals. It operates through three segments: Surfactants, Polymers and Specialty Products. Surfactants segment offers products, which are principal ingredients in consumer and industrial cleaning products, such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications of Surfactants include fabric softeners, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications, such as latex systems and composites. Polymers include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers. Specialty Products include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications.
Company Coordinates stock-summary
Company Details
Edens & Winnetka Road , NORTHFIELD IL : 60093
stock-summary
Tel: 1 847 44675001 847 4467500
stock-summary
https://www.stepan.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."